Literature DB >> 29945005

Risk Factors Associated with Neurologic Deterioration After Combined Direct and Indirect Revascularization in Patients with Moyamoya Disease on the East Coast of China.

Xiaolei Zhai1, Lei Mao2, Handong Wang3, Xin Zhang3, Chunhua Hang4, Wei Wu5, Yue Jia3, Liansong Liu1.   

Abstract

OBJECTIVE: Neurologic deterioration is the primary distinctive complication after revascularization surgery in patients with moyamoya disease (MMD). The present study investigated the risk factors for neurologic deterioration after combined direct and indirect revascularization in patients with MMD.
METHODS: A retrospective review of 123 patients with MMD undergoing 138 combined direct and indirect revascularization procedures was performed. Demographics, clinical manifestation, medical history, neurologic deterioration complications, and relevant information of the operation were recorded.
RESULTS: There were 25 (18.12%) postoperative neurologic deterioration complications (13 reversible neurologic deficits, 9 infarctions with neurologic sequelae, and 3 hemorrhages). Preoperative multiple symptom episodes and one-staged bilateral revascularization were significantly correlated with postoperative neurologic deterioration complications (P < 0.05 and P < 0.01, respectively). The incidence rate (26.39%) of postoperative neurologic deterioration in ischemic MMDs was significantly greater than hemorrhagic MMDs (7.69%; P < 0.01) In total, 34.78% of patients with transient ischemic attack onset and 22.45% of patients with infarction onset suffered from postoperative neurologic deterioration, and there was no significant difference between them (P > 0.05). Postoperative neurologic deterioration complications had no significant correlation with sex, age at the time of surgery, type of surgical procedure, unilateral MMD or not, interval between the last attack and operation, and history of thyroid disease, hypertension, and autoimmune disease.
CONCLUSIONS: Preoperative multiple symptom episodes and one-staged bilateral revascularization are risk factors associated with postoperative neurologic deterioration in patients with MMD. Therefore, 2 unilateral revascularization procedures performed successively rather than one-staged bilateral revascularization procedures should be performed in patients with bilateral MMD.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya disease; Postoperative complications; Revascularization; Risk factors

Mesh:

Year:  2018        PMID: 29945005     DOI: 10.1016/j.wneu.2018.06.125

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  4 in total

1.  High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with Moyamoya disease.

Authors:  Jiaxi Li; Yahui Zhao; Meng Zhao; Penghui Cao; Xingju Liu; Hao Ren; Dong Zhang; Yan Zhang; Rong Wang; Jizong Zhao
Journal:  Neurosurg Rev       Date:  2019-06-15       Impact factor: 3.042

2.  Cerebral Ischemic Complications After Surgical Revascularization for Moyamoya Disease: Risk Factors and Development of a Predictive Model Based on Preoperative Nutritional Blood Parameters.

Authors:  Fangbao Li; Chuanfeng Li; Yunwei Sun; Yue Bao; Wenbo Jiang; Zuoyan Song; Yongyi Wang; Mingxing Liu; Weimin Wang; Tong Li; Luo Li
Journal:  Front Nutr       Date:  2022-03-10

3.  High-resolution compressed sensing time-of-flight MR angiography outperforms CT angiography for evaluating patients with Moyamoya disease after surgical revascularization.

Authors:  Shujing Ren; Wei Wu; Chunqiu Su; Qianmiao Zhu; Michaela Schmidt; Yi Sun; Christoph Forman; Peter Speier; Xunning Hong; Shanshan Lu
Journal:  BMC Med Imaging       Date:  2022-04-07       Impact factor: 1.930

4.  A meta-analysis of comparisons of various surgical treatments for moyamoya diseases.

Authors:  Kai Lin; Shaohua Sui; Jing Zhao; Liyong Zhang; Kun Chen
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.